Browsing Over 390 Presentations
Sort By
Upcoming First
Poster Display
30P - Male breast cancer: A rural based peripheral cancer center experience
Presentation Number
30P
Speakers
- SACHIN KHANDELWAL (SANGRUR, India)
Date
20.11.2020
Poster Display
31P - The prognostic value of pre-treatment peripheral neutrophil-lymphocyte-ratio (NLR) and its correlation with mutant p53 expression in Indonesian triple negative breast cancer patients
Presentation Number
31P
Speakers
- Rosita Y. Purwanto (Yogyakarta, Indonesia)
Date
20.11.2020
Poster Display
32P - Clinicopathologic features and prognostic factors in male breast cancer: A single centre experience
Presentation Number
32P
Speakers
- Izzet Dogan (Istanbul, Turkey)
Date
20.11.2020
Poster Display
33P - FDG-PET predictivity of pathological axillary nodal status in carcinoma breast-upfront and post-neoadjuvant chemotherapy (NACT) setting
Presentation Number
33P
Speakers
- Krithikaa Sekar (Bangalore, India)
Date
20.11.2020
Poster Display
34P - Clinical significance of neoadjuvant dose-dense chemotherapy for II and III stage breast cancer: A meta-analysis of published studies
Presentation Number
34P
Speakers
- Meng chen Liu (Shijiazhuang, China)
Date
20.11.2020
Poster Display
35P - Pathological response to weekly nabpaclitaxel and carboplatin followed by anthracycline regimen in triple negative breast cancer
Presentation Number
35P
Speakers
- Goteti Sharat Chandra (New Delhi, India)
Date
20.11.2020
Poster Display
36P - Survival in patients with contralateral breast cancer
Presentation Number
36P
Speakers
- Sergey Kamishov (Tashkent, Uzbekistan)
Date
20.11.2020
Poster Display
37P - Correlation between haematological toxicity with quality of life in breast cancer patients after first-cycle chemotherapy
Presentation Number
37P
Speakers
- Felix Wijovi (Tangerang, Indonesia)
Date
20.11.2020
Poster Display
Breast cancer, locally advanced
Date
20.11.2020
Poster Display
38P - Evaluation of the prognostic value of innate immunity-related biomarkers in early breast cancer (BC)
Presentation Number
38P
Speakers
- Veronica Martini (Novara, Italy)
Date
20.11.2020
Poster Display
39P - CSF-1R inhibitor (C019199) enhances antitumor effect in combination with anti-PD-1 therapy on murine breast cancer models
Presentation Number
39P
Speakers
- Jiani Zheng (Xiamen, China)
Date
20.11.2020
Poster Display
40P - Molecular subtypes and imaging phenotypes of breast cancer: MRI
Presentation Number
40P
Speakers
- Yulduz N. Khatamovna (Tashkent, Uzbekistan)
Date
20.11.2020